iScience·Aug 18Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccineNon-randomized trial in peopleBlood and immune systemPaper
PLOS Medicine·Oct 2Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trialRandomized trial in 1,283 peopleInterventionsPaper
Med·Feb 2A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged miceExperiments in animalsInterventionsPaper
Immunity & Ageing·Sep 7Immune response to influenza vaccination in the elderly is altered by chronic medication useCohort study in peopleInfluenzaPaper
Vaccine·Dec 21Rabies pre-exposure prophylaxis elicits long-lasting immunity in humansCohort study in peoplePopulationsPaper